DELTA/ HU0000151956 /
6/7/2024 5:07:48 PM | Chg. +1.00 | Volume | Bid6/7/2024 | Ask5:15:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
79.40HUF | +1.28% | 432,556 Turnover: 34.4 mill. |
-Bid Size: - | -Ask Size: - | 30.41 bill.HUF | - | 30.42 |
GlobeNewswire
6/6
Midwest Technical Institute announces 2024 high school scholarship program winners
GlobeNewswire
6/3
Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of ...
GlobeNewswire
6/3
IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Soci...
GlobeNewswire
6/2
Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and Omn...
GlobeNewswire
5/24
Hometown Hero Honors Vets on Memorial Day By Donating a Portion of Holiday Sales to K9s for Warriors
GlobeNewswire
5/23
IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2...
GlobeNewswire
5/21
Plug, Airbus, Delta, Hartsfield-Jackson Atlanta International Airport Study Feasibility of Hydrogen ...
GlobeNewswire
5/14
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
GlobeNewswire
5/13
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Present...
GlobeNewswire
5/9
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
5/7
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery t...
GlobeNewswire
4/30
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
GlobeNewswire
4/30
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma